Evidence map›Paper›PMID 30682127›Full record

ArticlePloS one2019

A sequential Monte Carlo algorithm for inference of subclonal structure in cancer.

Oyetunji E Ogundijo, Kaiyi Zhu, Xiaodong Wang, Dimitris Anastassiou

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oyetunji E OgundijoDepartment of Electrical Engineering, Columbia University, New York, NY, United States of America.
Kaiyi ZhuDepartment of Electrical Engineering, Columbia University, New York, NY, United States of America.ORCID 0000-0002-0111-0848
Xiaodong WangDepartment of Electrical Engineering, Columbia University, New York, NY, United States of America.ORCID 0000-0001-9261-9422
Dimitris AnastassiouDepartment of Electrical Engineering, Columbia University, New York, NY, United States of America.ORCID 0000-0003-2459-909X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referred to as subclones, each of which is characterized by a distinct profile of genomic variations such as somatic mutations. Inferring the underlying clonal landscape has become an important topic in that it can help in understanding cancer development and progression, and thereby help in improving treatment. We describe a novel state-space model, based on the feature allocation framework and an efficient sequential Monte Carlo (SMC) algorithm, using the somatic mutation data obtained from tumor samples to estimate the number of subclones, as well as their characterization. Our approach, by design, is capable of handling any number of mutations. Via extensive simulations, our method exhibits high accuracy, in most cases, and compares favorably with existing methods. Moreover, we demonstrated the validity of our method through analyzing real tumor samples from patients from multiple cancer types (breast, prostate, and lung). Our results reveal driver mutation events specific to cancer types, and indicate clonal expansion by manual phylogenetic analysis. MATLAB code and datasets are available to download at: https://github.com/moyanre/tumor_clones.

Indexed as

MutationAlgorithmsCell CountClone CellsDisease ProgressionGenotypeHumansModels, TheoreticalMonte Carlo MethodNeoplasmsPhylogeny

Identifiers

PMID30682127
PMCPMC6347199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.